James F. Reddoch

EVP, Research & Investments, Royalty Pharma plc.

Companies

Royalty Pharma plcEVP, Research & Investments Jun 15, 2020 to Sep 30, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Royalty Pharma plc RPRX25,030 shares²$1.5M at $60.48Sep 30, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 28, 2022Sold 100,000 shares at $41.23 of Royalty Pharma plc²
Jun 8, 2022Sold 100,000 shares at $41.56 of Royalty Pharma plc³
May 27, 2022Sold 75,000 shares at $41.08 of Royalty Pharma plc⁴
May 19, 2022Sold 75,000 shares at $40.44 of Royalty Pharma plc⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRoyalty Pharma plc, EVP, Research & Investments
2
SEC EDGARRoyalty Pharma plc shares after the filing of Sep 30, 2022
3
SEC EDGARForm 4 filed Jun 10, 2022
4
SEC EDGARForm 4 filed May 31, 2022
5
SEC EDGARForm 4 filed May 23, 2022